Stable expression and characterisation of a human alpha 7 nicotinic subunit chimera: a tool for functional high-throughput screening

  1. Lookup NU author(s)
  2. Dr Emma Bell
Author(s)Craig PJ, Bose S, Zwart R, Beattie RE, Folly EA, Johnson LR, Bell E, Evans NM, Benedetti G, Pearson KH, McPhie GI, Volsen SG, Millar NS, Sher E, Broad LM
Publication type Article
JournalEuropean Journal of Pharmacology
Year2004
Volume502
Issue1-2
Pages31-40
ISSN (print)0014-2999
ISSN (electronic)1879-0712
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
A chimera comprising the N-terminal region of the human alpha7 nicotinic acetylcholine receptor, fused to the transmembrane/C-terminal domains of the mouse serotonin 5-HT3 receptor, was constructed. Injection of the chimera cDNA into Xenopus oocytes, or transient transfection in human embryonic kidney (HEK-293) cells, resulted in the expression of functional channels that were sensitive to nicotinic acetylcholine, but not serotonin receptor ligands. In both systems, the responses obtained from chimeric receptors inactivated more slowly than those recorded following activation of wild-type alpha7 receptors. A stable HEK-293 cell line expressing the human alpha7/mouse 5-HT3 chimera was established, which showed that the chimera displayed a similar pharmacological profile to wild-type alpha7 receptors. Use of this chimera in high-throughput screening may enable the identification of novel pharmacological agents that will help to define further the role of alpha7 nicotinic receptors in physiology and disease.
PublisherElsevier BV
URLhttp://dx.doi.org/10.1016/j.ejphar.2004.08.042
DOI10.1016/j.ejphar.2004.08.042
Actions    Link to this publication